🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/08/2002 | 44,11 | 45,78 | 44,00 | 44,69 | +2,83% | 4,04% | 6.195.462 |
| 05/08/2002 | 45,56 | 45,73 | 43,27 | 43,45 | -4,85% | 5,38% | 6.173.663 |
| 02/08/2002 | 45,18 | 47,08 | 45,07 | 45,67 | -0,19% | 4,46% | 7.029.670 |
| 01/08/2002 | 47,10 | 47,10 | 45,48 | 45,75 | -3,33% | 3,44% | 7.017.513 |
| 31/07/2002 | 46,09 | 47,33 | 45,10 | 47,33 | +2,25% | 4,84% | 7.520.867 |
| 30/07/2002 | 45,56 | 46,85 | 45,32 | 46,29 | +0,10% | 3,35% | 7.584.795 |
| 29/07/2002 | 45,31 | 46,35 | 44,78 | 46,24 | +5,35% | 3,45% | 10.087.419 |
| 26/07/2002 | 42,19 | 43,89 | 41,69 | 43,89 | +3,46% | 5,22% | 8.846.482 |
| 25/07/2002 | 40,27 | 42,98 | 39,94 | 42,42 | +4,37% | 7,54% | 12.004.002 |
| 24/07/2002 | 37,31 | 41,04 | 36,79 | 40,65 | +9,09% | 11,38% | 14.185.833 |
| 23/07/2002 | 37,84 | 38,65 | 36,74 | 37,26 | -2,40% | 5,04% | 12.019.826 |
| 22/07/2002 | 39,41 | 40,51 | 37,21 | 38,18 | -3,59% | 8,35% | 12.743.890 |
| 19/07/2002 | 40,09 | 40,71 | 39,55 | 39,60 | -1,19% | 2,88% | 12.485.662 |
| 18/07/2002 | 41,63 | 42,23 | 40,08 | 40,08 | -5,62% | 5,18% | 8.992.574 |
| 17/07/2002 | 42,56 | 43,65 | 41,52 | 42,46 | +1,11% | 5,02% | 10.095.070 |
| 16/07/2002 | 42,70 | 43,61 | 41,75 | 41,99 | -3,70% | 4,36% | 9.176.602 |
| 15/07/2002 | 42,94 | 45,04 | 40,91 | 43,61 | +0,33% | 9,62% | 13.194.215 |
| 12/07/2002 | 42,27 | 43,79 | 41,32 | 43,46 | +2,87% | 5,85% | 12.063.004 |
| 11/07/2002 | 40,82 | 42,85 | 40,17 | 42,25 | +1,63% | 6,57% | 19.090.997 |
| 10/07/2002 | 43,42 | 43,42 | 41,36 | 41,57 | -4,77% | 4,73% | 19.899.110 |
| 09/07/2002 | 44,95 | 45,23 | 43,19 | 43,65 | -4,31% | 4,54% | 14.705.641 |
| 08/07/2002 | 44,83 | 46,09 | 44,47 | 45,62 | -2,15% | 3,62% | 19.903.721 |
| 05/07/2002 | 45,32 | 46,66 | 45,32 | 46,62 | +3,34% | 2,95% | 4.089.296 |
| 03/07/2002 | 44,51 | 45,11 | 44,44 | 45,11 | +0,77% | 1,52% | 10.632.694 |
| 02/07/2002 | 46,71 | 46,76 | 44,42 | 44,77 | -3,75% | 5,01% | 9.363.880 |
| 01/07/2002 | 48,56 | 48,75 | 46,28 | 46,52 | -3,73% | 5,09% | 6.790.935 |
| 28/06/2002 | 48,00 | 49,09 | 47,58 | 48,32 | -0,47% | 3,16% | 7.595.485 |
| 27/06/2002 | 48,00 | 48,66 | 47,22 | 48,55 | +1,09% | 3,00% | 6.733.505 |
| 26/06/2002 | 45,80 | 48,43 | 45,42 | 48,02 | +2,61% | 6,56% | 9.401.608 |
| 25/06/2002 | 46,54 | 47,85 | 46,44 | 46,80 | -0,91% | 3,03% | 8.564.885 |